Positive preclinical efficacy data for MFC1040 in Sugen/chronic hypoxia animal model of severe PAH
- Details
- Published on 08 September 2016
Paris, September 9, 2016 – Mifcare announced today positive preclinical efficacy data for MFC1040 in the Sugen/chronic hypoxia rat model of severe pulmonary arterial hypertension (PAH) through collaboration with Inserm.
Download the press release (PDF)